BACKGROUND: Murine hindlimb reperfusion injury (I/R), is initiated by activation of the classical pathway of complement. Complement receptor-2 knockout mice (Cr2-/-) are protected from I/R injury due to defective B-1 cells with a resulting deficient natural immunoglobulin M (IgM) repertoire. Cr2-/- and wild type (WT) mice were studied to isolate the antibody or antibodies responsible for initiation of I/R. METHODS: IgM-secreting B-1 cell clones were produced with hybridoma technology from WT cells. Of 21 clones tested in murine I/R models, only 1 clone, CM22, was found to restore injury in protected mice. Cr2-/- mice reconstituted with IgM from individual clones, WT serum, or saline were subjected to 2 hours hindlimb ischemia and 3 hours reperfusion and compared with WT. RESULTS: Muscle injury in Cr2-/- mice reconstituted with CM22 was similar to injury in WT mice reconstituted with saline and Cr2-/- mice reconstituted with WT serum. This injury was 137% greater (P < .05) than in both Cr2-/- mice reconstituted with saline and those reconstituted with a different IgM clone, CM31. IgM and C3 deposition was found only on injured muscle of WT mice or Cr2-/- mice reconstituted with CM22 or WT serum. CONCLUSION: A single clone of self-reactive IgM, CM22, can initiate complement-dependent I/R injury. Copyright 2004 Elsevier Inc.
BACKGROUND:Murine hindlimb reperfusion injury (I/R), is initiated by activation of the classical pathway of complement. Complement receptor-2 knockout mice (Cr2-/-) are protected from I/R injury due to defective B-1 cells with a resulting deficient natural immunoglobulin M (IgM) repertoire. Cr2-/- and wild type (WT) mice were studied to isolate the antibody or antibodies responsible for initiation of I/R. METHODS: IgM-secreting B-1 cell clones were produced with hybridoma technology from WT cells. Of 21 clones tested in murine I/R models, only 1 clone, CM22, was found to restore injury in protected mice. Cr2-/- mice reconstituted with IgM from individual clones, WT serum, or saline were subjected to 2 hours hindlimb ischemia and 3 hours reperfusion and compared with WT. RESULTS:Muscle injury in Cr2-/- mice reconstituted with CM22 was similar to injury in WT mice reconstituted with saline and Cr2-/- mice reconstituted with WT serum. This injury was 137% greater (P < .05) than in both Cr2-/- mice reconstituted with saline and those reconstituted with a different IgM clone, CM31. IgM and C3 deposition was found only on injured muscle of WT mice or Cr2-/- mice reconstituted with CM22 or WT serum. CONCLUSION: A single clone of self-reactive IgM, CM22, can initiate complement-dependent I/R injury. Copyright 2004 Elsevier Inc.
Authors: Jalil Afnan; Cyrus Ahmadi-Yazdi; Eric G Sheu; Sean M Oakes; Francis D Moore Journal: Am J Physiol Regul Integr Comp Physiol Date: 2010-03-24 Impact factor: 3.619
Authors: Jean F Regal; Megan E Strehlke; Jenna M Peterson; Cameron R Wing; Jordan E Parker; Noel Fernando Nieto; Lynne T Bemis; Jeffrey S Gilbert; Sherry D Fleming Journal: Mol Immunol Date: 2016-08-30 Impact factor: 4.407
Authors: Andrew Elvington; Carl Atkinson; Liudmila Kulik; Hong Zhu; Jin Yu; Mark S Kindy; V Michael Holers; Stephen Tomlinson Journal: J Immunol Date: 2011-12-23 Impact factor: 5.422
Authors: Connor F Laule; Evan J Odean; Cameron R Wing; Kate M Root; Kendra J Towner; Cassandra M Hamm; Jeffrey S Gilbert; Sherry D Fleming; Jean F Regal Journal: Am J Physiol Heart Circ Physiol Date: 2019-08-09 Impact factor: 4.733
Authors: Eric G Sheu; Sean M Oakes; Cyrus Ahmadi-Yazdi; Jalil Afnan; Michael C Carroll; Francis D Moore Journal: Surgery Date: 2009-08 Impact factor: 3.982
Authors: Sebastian Weckbach; Miriam Neher; Justin T Losacco; Ashley L Bolden; Liudmila Kulik; Michael A Flierl; Scott E Bell; V Michael Holers; Philip F Stahel Journal: J Neurotrauma Date: 2012-04-10 Impact factor: 5.269